Drug resistance is one of the main hurdles for the successful treatment of breast cancer. The synchronous targeting of apoptosis resistance and survival signal transduction pathways may be a promising approach to overcome drug resistance. In this study. we determined that evodiamine (EVO). https://www.missouriquiltcoes.shop/product-category/webbing/